European partnership fostering a European Research Area (ERA) for health research (Phase 2)

This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of Destination “Tackling diseases and reducing disease burden”. To that end, the proposal under this topic should aim to deliver results that are directed, tailored towards and contributing to all the following expected outcomes:

• Based on a trusted governance and effective working modalities, research funders, health policymakers and the research community work together in order to identify and prioritise topics of common interest and European benefit;
• Research funders and policymakers support the generation of knowledge related, but not limited, to cardiovascular diseases, prevention and public health, diet related diseases and nano medical technologies, and have access to and make use of the evidence on the benefits and drawbacks of health interventions, in particular for optimising clinical management, patient safety, personalised medicine (coordinating with the European Partnership for Personalised Medicine) and avoiding overtreatment;
• In addition to the well-established regular Joint Transnational Calls in the area of pre-clinical research, research funders and policymakers use the funding scheme developed in the Phase 1 of the European partnership fostering a European Research Area (ERA) for health research (ERA4Health) to support testing of health interventions in the clinical setting at European level. Therefore, the research community, independently from private interest, can conduct large-scale multi-country Investigator-Initiated Clinical Studies (IICSs)^[1] of various health interventions addressing important public health needs in a seamless way, effectively addressing known challenges and obstacles related to, for example, appropriate study design, ethics (including special patient groups^[2]), regulatory and institutional approvals, patient recruitment, management of informed consent, as well as, biobanking of human samples;
• Public health research systems in the ERA are more effective and integrated. Utilisation of health services, preventative measures, technologies, tools and digital solutions are more cost-effective;
• Health and care authorities, policymakers and other stakeholders use the research results to develop evidence-based strategies and policies, and deploy good practices to European countries and regions;
• Patients and citizens are more knowledgeable about disease threats and contribute to a patient-centred decision-making process, assuring better adherence to knowledge-based disease management strategies and policies;
• Countries cooperate better and use context-specific knowledge and evidence to make their health and care systems more sustainable and resilient with respect to upcoming needs and crises (complementary with other current and future co-funded European Partnerships with which strong links will be established).

Interested parties can find more information and apply on the Funding and Tenders Portal.